Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment

Triple-negative breast cancer (TNBC) is one of the most heterogeneous and aggressive breast cancer subtypes with a high risk of death on recurrence. To date, TNBC is very difficult to treat due to the lack of an effective targeted therapy. However, recent advances in the molecular characterization o...

Descripción completa

Detalles Bibliográficos
Autores principales: Masci, Domiziana, Naro, Chiara, Puxeddu, Michela, Urbani, Andrea, Sette, Claudio, La Regina, Giuseppe, Silvestri, Romano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672974/
https://www.ncbi.nlm.nih.gov/pubmed/38005235
http://dx.doi.org/10.3390/molecules28227513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672974/
https://www.ncbi.nlm.nih.gov/pubmed/38005235
http://dx.doi.org/10.3390/molecules28227513

Ejemplares similares